The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability
Open accessAbstract
The Akt family of serine/threonine protein kinases are key regulators of multiple aspects of cell behaviour, including proliferation, survival, metabolism, and tumorigenesis. Growth-factor-activated Akt signalling promotes progression through normal, unperturbed cell cycles by acting on diverse downstream factors involved in controlling the G1/S and G2/M transitions. Remarkably, several recent studies have also implicated Akt in modulating DNA damage responses and genome stability. High Akt activity can suppress ATR/Chk1 signalling and homologous recombination repair (HRR) via direct phosphorylation of Chk1 or TopBP1 or, indirectly, by inhibiting recruitment of double-strand break (DSB) resection factors, such as RPA, Brca1, and Rad51, to sites of damage. Loss of checkpoint and/or HRR proficiency is therefore a potential cause of genomic instability in tumor cells with high Akt. Conversely, Akt is activated by DNA double-strand breaks (DSBs) in a DNA-PK- or ATM/ATR-dependent manner and in some circumstances can contribute to radioresistance by stimulating DNA repair by nonhomologous end joining (NHEJ). Akt therefore modifies both the response to and repair of genotoxic damage in complex ways that are likely to have important consequences for the therapy of tumors with deregulation of the PI3K-Akt-PTEN pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: A cell cycle regulatory network controlling NF‐κB subunit activity and function
Barré, B., & Perkins, N. D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601899 · Cited by 106
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“In normal cells p53 is maintained at very low levels, and Mdm2 targets p53 for ubiquitination and allows export of p53 from the nucleus to the cytoplasm where proteolysis takes place [71, 72].”
BackgroundHigh Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“In normal cells p53 is maintained at very low levels, and Mdm2 targets p53 for ubiquitination and allows export of p53 from the nucleus to the cytoplasm where proteolysis takes place [71, 72].”
BackgroundMaehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Mechanism of activation of protein kinase B by insulin and IGF-1.
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,004
Hoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
The PI3K‒PDK1 connection: more than just a road to PKB
Vanhaesebroeck, B., & Alessi, D. R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460561 · Cited by 1,644
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D. R., Cantley, L. C., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,460
Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia
Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80086-0 · Cited by 1,458
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
(2010) · Advances in Cancer Research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,276
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
Dual Role of Phosphatidylinositol-3,4,5-trisphosphate in the Activation of Protein Kinase B
Stokoe, D., Stephens, L. R., Copeland, T., Gaffney, P. R. J., Reese, C. B., Painter, G. F., Holmes, A. B., McCormick, F., & Hawkins, P. T. (1997) · Science · doi:10.1126/science.277.5325.567 · Cited by 1,201
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092
Mechanism and regulation of human non-homologous DNA end-joining
Lieber, M. R., Ma, Y., Pannicke, U., & Schwarz, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1202 · Cited by 973
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F., & Birnbaum, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100462200 · Cited by 959
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948
Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene
Chen, W. S., Xu, P.-Z., Gottlob, K., Chen, M.-L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., et al. (2001) · Genes & Development · doi:10.1101/gad.913901 · Cited by 928
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Gao, T., Furnari, F., & Newton, A. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.008 · Cited by 906
Brognard, J., Clark, A. S., Ni, Y., & Dennis, P. A. (2001) · PubMed · Cited by 905
Hirai, H., Sootome, H., Nakatsuru, Y., Miyama, K., Taguchi, S., Tsujioka, K., Ueno, Y., Hatch, H., Majumder, P. K., Pan, B.-S., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1012 · Cited by 860
Shin, I., Yakes, F. M., Rojo, F., Shin, N.-Y., Bakin, A. V., Baselga, J., & Arteaga, C. L. (2002) · Nature Medicine · doi:10.1038/nm759 · Cited by 790
TopBP1 Activates the ATR-ATRIP Complex
Kumagai, A., Lee, J., Yoo, H. Y., & Dunphy, W. G. (2006) · Cell · doi:10.1016/j.cell.2005.12.041 · Cited by 746
Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., & Testa, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9267 · Cited by 736
Garofalo, R. S., Orena, S. J., Rafidi, K., Torchia, A. J., Stock, J. L., Hildebrandt, A. L., Coskran, T., Black, S. C., Brees, D. J., Wicks, J. R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16885 · Cited by 726
Viglietto, G., Motti, M. L., Bruni, P., Melillo, R. M., D'Alessio, A., Califano, D., Vinci, F., Chiappetta, G., Tsichlis, P., Bellacosa, A., et al. (2002) · Nature Medicine · doi:10.1038/nm762 · Cited by 701
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700
DNA double-strand break repair: From mechanistic understanding to cancer treatment
HELLEDAY, T., LO, J., VANGENT, D., & ENGELWARD, B. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.006 · Cited by 640 · cited 11×
“Thus, the inhibitory effect of Akt on ATR-Chk1 signalling and HRR could be due to suppression of DNA damage processing [122].”
BackgroundInfluentialAkt Enhances Mdm2-mediated Ubiquitination and Degradation of p53
Ogawara, Y., Kishishita, S., Obata, T., Isazawa, Y., Suzuki, T., Tanaka, K., Masuyama, N., & Gotoh, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109745200 · Cited by 617 · cited 1×
“In response to growth factor stimulation, active Akt binds to and phosphorylates Mdm2 at Ser166 and Ser186 to enhance protein stability and facilitate the function of Mdm2 to promote p53 ubiquitination [73, 74].”
BackgroundCalcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway
Yano, S., Tokumitsu, H., & Soderling, T. R. (1998) · Nature · doi:10.1038/25147 · Cited by 610
Mutations in a signalling pathway
Parsons, D. W., Wang, T.-L., Samuels, Y., Bardelli, A., Cummins, J. M., DeLong, L., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599
Brognard, J., Sierecki, E., Gao, T., & Newton, A. C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.017 · Cited by 591
Clark, A. S., West, K. A., Streicher, S. A., & Dennis, P. A. (2002) · PubMed · Cited by 589
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
Ali, I. U., Schriml, L. M., & Dean, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1922 · Cited by 542
Yap, T. A., Yan, L., Patnaik, A., Fearen, I., Olmos, D., Papadopoulos, K., Baird, R. D., Delgado, L., Taylor, A., Lupinacci, L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5263 · Cited by 539
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Sonoda, E., Hochegger, H., Saberi, A., Taniguchi, Y., & Takeda, S. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.022 · Cited by 525
Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
Ahmed, N. N., Grimes, H. L., Bellacosa, A., Chan, T. O., & Tsichlis, P. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3627 · Cited by 519
Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase
Feng, J., Park, J., Cron, P., Hess, D., & Hemmings, B. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406731200 · Cited by 488
COFFER, P. J., & WOODGETT, J. R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16305.x · Cited by 487
Haas-Kogan, D., Shalev, N., Wong, M., Mills, G., Yount, G., & Stokoe, D. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00493-9 · Cited by 477
The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27
Ganoth, D., Bornstein, G., Ko, T. K., Larsen, B., Tyers, M., Pagano, M., & Hershko, A. (2001) · Nature Cell Biology · doi:10.1038/35060126 · Cited by 467
PTEN function: how normal cells control it and tumour cells lose it
LESLIE, N. R., & DOWNES, C. P. (2004) · Biochemical Journal · doi:10.1042/bj20040825 · Cited by 451
Cell cycle regulation by the Cdc25 phosphatase family
Nilsson, I., & Hoffmann, I. (2000) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-4253-7_10 · Cited by 450
Li, Y., Dowbenko, D., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109062200 · Cited by 442
PIK3CA as an oncogene in cervical cancer
Ma, Y.-Y., Wei, S.-J., Lin, Y.-C., Lung, J.-C., Chang, T.-C., Whang-Peng, J., Liu, J. M., Yang, D.-M., Yang, W. K., & Shen, C.-Y. (2000) · Oncogene · doi:10.1038/sj.onc.1203597 · Cited by 434
Balendran, A., Casamayor, A., Deak, M., Paterson, A., Gaffney, P., Currie, R., Downes, C. P., & Alessi, D. R. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80186-9 · Cited by 429
Nonhomologous End Joining in Yeast
Daley, J. M., Palmbos, P. L., Wu, D., & Wilson, T. E. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.073003.113340 · Cited by 415
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A., & Roy, K. (2003) · PubMed · Cited by 407
Phosphatidylinositol 3-Kinase Couples the Interleukin-2 Receptor to the Cell Cycle Regulator E2F
Brennan, P., Babbage, J. W., Burgering, B. M. T., Groner, B., Reif, K., & Cantrell, D. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80388-x · Cited by 404
PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
Bozulic, L., Surucu, B., Hynx, D., & Hemmings, B. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.024 · Cited by 386
Rössig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., & Dimmeler, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5644-5657.2001 · Cited by 370
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
Linares, L. K., Hengstermann, A., Ciechanover, A., Müller, S., & Scheffner, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2030930100 · Cited by 361
Akt-dependent Phosphorylation of p27Kip1Promotes Binding to 14-3-3 and Cytoplasmic Localization
Fujita, N., Sato, S., Katayama, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203668200 · Cited by 358
A CDK-Independent Function of Mammalian Cks1
Spruck, C., Strohmaier, H., Watson, M., Smith, A. P. L., Ryan, A., Krek, W., & Reed, S. I. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00210-6 · Cited by 356
Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
Markman, B., Dienstmann, R., & Tabernero, J. (2010) · Oncotarget · doi:10.18632/oncotarget.188 · Cited by 355
PTEN: from pathology to biology
Sulis, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00175-2 · Cited by 344
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis
Roy, H. K. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.201 · Cited by 343
Gupta, A., McKenna, W. G., Weber, C. N., Feldman, M. D., Goldsmith, J. D., Mick, R., Machtay, M. X., Rosenthal, D. I., Bakanauskas, V. J., Cerniglia, G. J., et al. (2002) · PubMed · Cited by 343
Impact of the KU80 Pathway on NHEJ-Induced Genome Rearrangements in Mammalian Cells
Guirouilh-Barbat, J., Huck, S., Bertrand, P., Pirzio, L., Desmaze, C., Sabatier, L., & Lopez, B. S. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.008 · Cited by 335
Structural Basis for Discrimination of 3-Phosphoinositides by Pleckstrin Homology Domains
Ferguson, K. M., Kavran, J. M., Sankaran, V. G., Fournier, E., Isakoff, S. J., Skolnik, E. Y., & Lemmon, M. A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00037-x · Cited by 334
Tang, J.-M., He, Q.-Y., Guo, R.-X., & Chang, X.-J. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2005.10.003 · Cited by 332
Lack of PTEN sequesters CHK1 and initiates genetic instability
Puc, J., Keniry, M., Li, H. S., Pandita, T. K., Choudhury, A. D., Memeo, L., Mansukhani, M., Murty, V. V. V. S., Gaciong, Z., Meek, S. E. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.009 · Cited by 328
Mechanisms of p53-mediated apoptosis
Bates, S., & Vousden, K. H. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050267 · Cited by 305
Chen, B. P. C., Uematsu, N., Kobayashi, J., Lerenthal, Y., Krempler, A., Yajima, H., Löbrich, M., Shiloh, Y., & Chen, D. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611605200 · Cited by 296
Rodier, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6672 · Cited by 286
Physiological functions of protein kinase B/Akt
Yang, Z.-Z., Tschopp, O., Baudry, A., Dümmler, B., Hynx, D., & Hemmings, B. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320350 · Cited by 283
Activation of Akt/Protein Kinase B Overcomes a G 2 /M Cell Cycle Checkpoint Induced by DNA Damage
Kandel, E. S., Skeen, J., Majewski, N., Di Cristofano, A., Pandolfi, P. P., Feliciano, C. S., Gartel, A., & Hay, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7831-7841.2002 · Cited by 278
Carnero, A. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941865 · Cited by 272
Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATM
Viniegra, J. G., Martínez, N., Modirassari, P., Losa, J. H., Cobo, C. P., Lobo, V. J. S.-A., Luquero, C. I. A., Álvarez-Vallina, L., Ramón y Cajal, S., Rojas, J. M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410344200 · Cited by 270
Gao, D., Inuzuka, H., Tseng, A., Chin, R. Y., Toker, A., & Wei, W. (2009) · Nature Cell Biology · doi:10.1038/ncb1847 · Cited by 267
Structural Basis of 3-Phosphoinositide Recognition by Pleckstrin Homology Domains
Lietzke, S. E., Bose, S., Cronin, T., Klarlund, J., Chawla, A., Czech, M. P., & Lambright, D. G. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00038-1 · Cited by 266
Mechanism of Protein Kinase B Activation by Cyclic AMP-Dependent Protein Kinase
Filippa, N., Sable, C. L., Filloux, C., Hemmings, B., & Van Obberghen, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4989 · Cited by 258
Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability
Richardson, C., Stark, J. M., Ommundsen, M., & Jasin, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207098 · Cited by 255
Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects
Zachos, G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg060 · Cited by 246
Knobbe, C. B., & Reifenberger, G. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00481.x · Cited by 238
Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes
Gartel, A. L., & Shchors, K. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00020-4 · Cited by 238
The Ras radiation resistance pathway.
Gupta, A. K., Bakanauskas, V. J., Cerniglia, G. J., Cheng, Y., Bernhard, E. J., Muschel, R. J., & McKenna, W. G. (2001) · PubMed · Cited by 238
Progress in Cell Cycle Research
(1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7 · Cited by 237
Lin, H.-K., Wang, G., Chen, Z., Teruya-Feldstein, J., Liu, Y., Chan, C.-H., Yang, W.-L., Erdjument-Bromage, H., Nakayama, K. I., Nimer, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1849 · Cited by 234
Kao, G. D., Jiang, Z., Fernandes, A. M., Gupta, A. K., & Maity, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703042200 · Cited by 228
Akt inhibitors in clinical development for the treatment of cancer
Pal, S. K., Reckamp, K., Yu, H., & Figlin, R. A. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.520701 · Cited by 226
Hrr25-dependent phosphorylation state regulates organization of the pre-40S subunit
Schäfer, T., Maco, B., Petfalski, E., Tollervey, D., Böttcher, B., Aebi, U., & Hurt, E. (2006) · Nature · doi:10.1038/nature04840 · Cited by 220
Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition
Okumura, E., Fukuhara, T., Yoshida, H., Hanada, S.-I., Kozutsumi, R., Mori, M., Tachibana, K., & Kishimoto, T. (2002) · Nature Cell Biology · doi:10.1038/ncb741 · Cited by 213
Toulany, M., Kasten-Pisula, U., Brammer, I., Wang, S., Chen, J., Dittmann, K., Baumann, M., Dikomey, E., & Rodemann, H. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2454 · Cited by 206
Brodbeck, D., Cron, P., & Hemmings, B. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9133 · Cited by 204
Golding, S. E., Morgan, R. N., Adams, B. R., Hawkins, A. J., Povirk, L. F., & Valerie, K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.7927 · Cited by 202
Phosphorylation of HDM2 by Akt
Ashcroft, M., Ludwig, R. L., Woods, D. B., Copeland, T. D., Weber, H. O., MacRae, E. J., & Vousden, K. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205276 · Cited by 197
Implication of Mammalian Ribosomal Protein S3 in the Processing of DNA Damage
Kim, J., Chubatsu, L. S., Admon, A., Stahl, J., Fellous, R., & Linn, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13620 · Cited by 194
Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis
Maddika, S., Ande, S. R., Wiechec, E., Hansen, L. L., Wesselborg, S., & Los, M. (2008) · Journal of Cell Science · doi:10.1242/jcs.009530 · Cited by 193
Human MRE11 is inactivated in mismatch repair‐deficient cancers
Giannini, G., Ristori, E., Cerignoli, F., Rinaldi, C., Zani, M., Viel, A., Ottini, L., Crescenzi, M., Martinotti, S., Bignami, M., et al. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf044 · Cited by 188
Toulany, M., Kehlbach, R., Florczak, U., Sak, A., Wang, S., Chen, J., Lobrich, M., & Rodemann, H. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2200 · Cited by 186
Molecular cloning of a second form of rac protein kinase.
Jones, P. F., Jakubowicz, T., & Hemmings, B. A. (1991) · Cell Regulation · doi:10.1091/mbc.2.12.1001 · Cited by 186
Byun, D., Cho, K., Ryu, B., Lee, M., Park, J., Chae, K., Kim, H., & Chi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.10962 · Cited by 184
Gupta, A. K., Cerniglia, G. J., Mick, R., Ahmed, M. S., Bakanauskas, V. J., Muschel, R. J., & McKenna, W. G. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00214-1 · Cited by 184
ATR signaling can drive cells into senescence in the absence of DNA breaks
Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R., & Fernandez-Capetillo, O. (2008) · Genes & Development · doi:10.1101/gad.452308 · Cited by 183
PHLiPPing the switch on Akt and protein kinase C signaling
Brognard, J., & Newton, A. C. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.04.001 · Cited by 183
Kim, I.-A., Bae, S.-S., Fernandes, A., Wu, J., Muschel, R. J., McKenna, W. G., Birnbaum, M. J., & Bernhard, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0513 · Cited by 179
A Role for PI 3-Kinase and PKB Activity in the G2/M Phase of the Cell Cycle
Shtivelman, E., Sussman, J., & Stokoe, D. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00843-6 · Cited by 178
Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis
Karlsson, C., Katich, S., Hagting, A., Hoffmann, I., & Pines, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.3.573 · Cited by 178
Chen, M., Pratt, C. P., Zeeman, M. E., Schultz, N., Taylor, B. S., O'Neill, A., Castillo-Martin, M., Nowak, D. G., Naguib, A., Grace, D. M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.013 · Cited by 177
Li, B., Yuan, M., Kim, I.-A., Chang, C.-M., Bernhard, E. J., & Shu, H.-K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207602 · Cited by 168
cAMP stimulates protein kinase B in a Wortmannin‐insensitive manner
Sable, C. L., Filippa, N., Hemmings, B., & Van Obberghen, E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00518-8 · Cited by 166
Katayama, K., Fujita, N., & Tsuruo, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5725-5737.2005 · Cited by 164
Characterization of a carboxy-terminal BRCA1 interacting protein
Wong, A. K., Ormonde, P. A., Pero, R., Chen, Y., Lian, L., Salada, G., Berry, S., Lawrence, Q., Dayananth, P., Ha, P., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202150 · Cited by 162
RING Domain–Mediated Interaction Is a Requirement for MDM2's E3 Ligase Activity
Kawai, H., Lopez-Pajares, V., Kim, M. M., Wiederschain, D., & Yuan, Z.-M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1313 · Cited by 161
Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis
Liu, J., Weiss, H. L., Rychahou, P. G., Jackson, L. N., Evers, B. M., & Gao, T. (2008) · Oncogene · doi:10.1038/onc.2008.450 · Cited by 160
14‐3‐3 suppresses the nuclear localization of threonine 157‐phosphorylated p27Kip1
Sekimoto, T., Fukumoto, M., & Yoneda, Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600198 · Cited by 159
Identification and functional analysis of TopBP1 and its homologs
Garcia, V., Furuya, K., & Carr, A. M. (2005) · DNA Repair · doi:10.1016/j.dnarep.2005.04.001 · Cited by 158
Van Ummersen, L., Binger, K., Volkman, J., Marnocha, R., Tutsch, K., Kolesar, J., Arzoomanian, R., Alberti, D., & Wilding, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0406 · Cited by 158
Hirose, Y., Katayama, M., Mirzoeva, O. K., Berger, M. S., & Pieper, R. O. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2633 · Cited by 154
p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK
Boehme, K. A., Kulikov, R., & Blattner, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703423105 · Cited by 153
Increased levels of p21WAF1/Cip1 in human brain tumors.
Jung, J., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, Y., Levin, V. A., & Zhang, W. (1995) · PubMed · Cited by 153
Edwards, E., Geng, L., Tan, J., Onishko, H. M., Donnelly, E. F., & Hallahan, D. E. (2002) · PubMed · Cited by 152
Woenckhaus, J., Steger, K., Werner, E., Fenic, I., Gamerdinger, U., Dreyer, T., & Stahl, U. (2002) · The Journal of Pathology · doi:10.1002/path.1207 · Cited by 152
Barnett, S., Bilodeau, M. T., & Lindsley, C. W. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053507714 · Cited by 146
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin
Altomare, D. A., Lyons, G. E., Mitsuuchi, Y., Cheng, J. Q., & Testa, J. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201750 · Cited by 138
Negative Regulation of AKT Activation by BRCA1
Tao, X., Ohashi, A., Huang, Y., Pandita, T. K., Ludwig, T., Powell, S. N., & Yang, Q. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3009 · Cited by 134
AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51
Plo, I., Laulier, C., Gauthier, L., Lebrun, F., Calvo, F. M., & López, B. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0861 · Cited by 132
Targeting Akt in cancer therapy
LoPiccolo, J., Granville, C. A., Gills, J. J., & Dennis, P. A. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280cc2c6f · Cited by 129
Lee, C. M., Fuhrman, C. B., Planelles, V., Peltier, M. R., Gaffney, D. K., Soisson, A. P., Dodson, M. K., Tolley, H. D., Green, C. L., & Zempolich, K. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1084 · Cited by 128
Why size matters: altering cell size
Saucedo, L. J., & Edgar, B. A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00341-6 · Cited by 124
Komai, N., Morita, Y., Sakuta, T., Kuwabara, A., & Kashihara, N. (2007) · Modern Rheumatology · doi:10.1007/s10165-007-0605-8 · Cited by 121
Altiok, S., Batt, D. B., Altıok, N., Papautsky, A., Downward, J., Roberts, T. M., & Avraham, H. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32274 · Cited by 120
Lindsley, C. W. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790980602 · Cited by 114
Regulation of CDC25B phosphatases subcellular localization
Davezac, N., Baldin, V., Gabrielli, B. G., Forrest, A. R. R., Theis‐Febvre, N., Yashida, M., & Ducommun, B. (2000) · Oncogene · doi:10.1038/sj.onc.1203545 · Cited by 114
Grana, T. M., Rusyn, E. V., Zhou, H., Sartor, C. I., & Cox, A. D. (2002) · PubMed · Cited by 114
Regulation of TopBP1 oligomerization by Akt/PKB for cell survival
Liu, K., Paik, J. C., Wang, B., Lin, F., & Lin, W.-C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601355 · Cited by 104
PI3K/Akt/mTOR Pathway Inhibitors in Cancer: A Perspective on Clinical Progress
Wu, P., & Hu, Y.-Z. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793361234 · Cited by 103
Estrogen Inhibits ATR Signaling to Cell Cycle Checkpoints and DNA Repair
Pedram, A., Razandi, M., Evinger, A. J., Lee, E., & Levin, E. R. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0085 · Cited by 98
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
Altomare, D., Guo, K., Cheng, J., Sonoda, G., Walsh, K., & Testa (1995) · PubMed · Cited by 98
Lu, D., Huang, J., & Basu, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603390200 · Cited by 96
PTEN: Sometimes Taking It Off Can Be Better than Putting It On
Myers, M. P., & Tonks, N. K. (1997) · The American Journal of Human Genetics · doi:10.1086/301659 · Cited by 94
Glial Cell Line-derived Neurotrophic Factor Increases Intracellular Calcium Concentration
Pérez‐García, M. J., Ceña, V., de Pablo, Y., Llovera, M., Comella, J. X., & Soler, R. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308367200 · Cited by 93
Walker, M., Black, E. J., Oehler, V., Gillespie, D. A., & Scott, M. T. (2009) · Oncogene · doi:10.1038/onc.2009.102 · Cited by 91
Self-citationZachos, G., Rainey, M. D., & Gillespie, D. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.2.563-574.2005 · Cited by 89
Self-citationCaporali, S., Levati, L., Starace, G., Ragone, G., Bonmassar, E., Alvino, E., & D’Atri, S. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044743 · Cited by 87
Metastatic Potential of 21T Human Breast Cancer Cells Depends on Akt/Protein Kinase B Activation
Qiao, M., Iglehart, J. D., & Pardee, A. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0877 · Cited by 86
Lee, S. B., Kwon, I., Park, J., Lee, K.-H., Ahn, Y., Lee, C., Kim, J., Choi, S. Y., Cho, S. W., & Ahn, J.-Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131367 · Cited by 84
Deng, R., Tang, J., Ma, J.-G., Chen, S.-P., Xia, L.-P., Zhou, W.-J., Li, D., Feng, G.-K., Zeng, Y.-X., & Zhu, X.-F. (2010) · Oncogene · doi:10.1038/onc.2010.467 · Cited by 82
Tsai, M., Kuo, Y., Chiu, Y., Su, Y.-C., & Lin, Y. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173146 · Cited by 82
Inhibition of Chk1 by Activated PKB/Akt
King, F. W., Skeen, J. E., Hay, N., & Shtivelman, E. (2004) · Cell Cycle · doi:10.4161/cc.3.5.894 · Cited by 81
Henry, M. K., Lynch, J. T., Eapen, A. K., & Quelle, F. W. (2001) · Blood · doi:10.1182/blood.v98.3.834 · Cited by 80
Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding
Lopez-Pajares, V., Kim, M. M., & Yuan, Z.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710030200 · Cited by 79
Akt/PKB suppresses DNA damage processing and checkpoint activation in late G2
Xu, N., Hégarat, N., Black, E. J., Scott, M. T., Hochegger, H., & Gillespie, D. A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201003004 · Cited by 78
Self-citationHomologous Recombination and Its Role in Carcinogenesis
Bishop, A. J. R., & Schiestl, R. H. (2002) · BioMed Research International · doi:10.1155/s1110724302204052 · Cited by 77
The coupling of cell growth to the cell cycle
Tapon, N., Moberg, K. H., & Hariharan, I. K. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00284-2 · Cited by 76
Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Lindsley, C. W., Stanley, B., Melissa, Y., et al. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607781696864 · Cited by 72
Maddika, S., Panigrahi, S., Wiecheć, E., Wesselborg, S., Fischer, U., Schulze‐Osthoff, K., & Łoś, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00668-08 · Cited by 69
Behind the wheel and under the hood: Functions of cyclin-dependent kinases in response to DNA damage
Wohlbold, L., & Fisher, R. P. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.009 · Cited by 67
Wallin, J. J., Guan, J., Prior, W. W., Edgar, K. A., Kassees, R., Sampath, D., Belvin, M. P., & Friedman, L. S. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000630 · Cited by 62
GOTTSCHALK, A. R., Doan, A., Nakamura, J. L., Stokoe, D., & Haas-Kogan, D. A. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.08.014 · Cited by 58
Ko, J., Ciou, S., Jhan, J.-Y., Cheng, C., Su, Y.-J., Chuang, S., Lin, S., Chang, C., & Lin, Y. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0051 · Cited by 48
PKB/Akt phosphorylates the CDC25B phosphatase and regulates its intracellular localisation
Baldin, V., Theis‐Febvre, N., Benne, C., Froment, C., Cazalès, M., Burlet‐Schiltz, O., & Ducommun, B. (2003) · Biology of the Cell · doi:10.1016/j.biolcel.2003.08.001 · Cited by 43
The Molecular Basis and Clinical Management of Ataxia Telangiectasia
Spacey, S. D., Gatti, R. A., & Bebb, G. D. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000822 · Cited by 41
DNA damage-induced signalling in ataxia-telangiectasia and related syndromes
Lavin, M. F., & Kozlov, S. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.032 · Cited by 40
Tonic, I., Yu, W.-N., Park, Y., Chen, C.-C., & Hay, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.104372 · Cited by 39
Knockdown of ribosomal protein S3 protects human cells from genotoxic stress
Hegde, V. K., Yadavilli, S., & Deutsch, W. A. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.09.004 · Cited by 36
Plo, I., & López, B. S. (2009) · Oncogene · doi:10.1038/onc.2009.85 · Cited by 30
Hinton, C. V., Fitzgerald, L. D., & Thompson, M. E. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.03.008 · Cited by 28
Multiple roles and therapeutic implications of Akt signaling in cancer
Bolós, V., Calvo, E., Bolós, V., & Grande, E. (2009) · OncoTargets and Therapy · doi:10.2147/ott.s4943 · Cited by 27
Effects of ectopic expression of Drosophila DNA glycosylases dOgg1 and RpS3 in mitochondria
Radyuk, S. N., Michalak, K., Rebrin, I., Sohal, R. S., & Orr, W. C. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.021 · Cited by 24
Miralem, T., & Avraham, H. K. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.579-593.2003 · Cited by 21
Akt signaling: a damaging interaction makes good
Toker, A. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.05.003 · Cited by 17
PIKK-ing a New Partner: A New Role for PKB in the DNA Damage Response
Lees‐Miller, S. P. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.010 · Cited by 13
Cited by
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J., Marino, M., Martinez-Chantar, M. L., Nawroth, R., Sanchez-Garcia, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 778
Astaxanthin in Skin Health, Repair, and Disease: A Comprehensive Review
Davinelli, S., Nielsen, M. E., & Scapagnini, G. (2018) · Nutrients · doi:10.3390/nu10040522 · Cited by 473
PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Fattahi, S., Amjadi-Moheb, F., Tabaripour, R., Ashrafi, G. H., & Akhavan-Niaki, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118513 · Cited by 400
Metadata
- Authors
- Xu, N., Lao, Y., Zhang, Y., & Gillespie, D. A.
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2012
- Volume
- 2012
- Pages
- 1-15
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W2009214383
- Cited by
- 302
- References
- 186
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.